百花医药：2025年上半年净利润2548.34万元，同比增长12.45%

Core Viewpoint - The company reported a revenue of 202 million yuan for the first half of 2025, reflecting a year-on-year growth of 2.95% and a net profit of 25.48 million yuan, which represents a year-on-year increase of 12.45% [1] Financial Performance - Revenue for the first half of 2025 reached 202 million yuan, marking a 2.95% increase compared to the previous year [1] - Net profit for the same period was 25.48 million yuan, showing a growth of 12.45% year-on-year [1]